Explore the words cloud of the HARMONY project. It provides you a very rough idea of what is the project "HARMONY" about.
The following table provides information about the project.
Coordinator |
FUNDACION INSTITUTO DE ESTUDIOS DE CIENCIAS DE LA SALUD DE CASTILLA Y LEON
Organization address contact info |
Coordinator Country | Spain [ES] |
Project website | https://www.harmony-alliance.eu/ |
Total cost | 42˙205˙587 € |
EC max contribution | 20˙200˙000 € (48%) |
Programme |
1. H2020-EU.3.1.7. (Innovative Medicines Initiative 2 (IMI2)) |
Code Call | H2020-JTI-IMI2-2015-06-two-stage |
Funding Scheme | IMI2-RIA |
Starting year | 2017 |
Duration (year-month-day) | from 2017-01-01 to 2021-12-31 |
Take a look of project's partnership.
Despite significant recent progress in the field of hematological malignancies (HMs), with increasing survival rates and improvement in quality of life, many children and adults with HMs still die from these disorders or experience disabling complications. Therefore, improvement of health care of HMs is an unmet medical need. Thus, it is important to define and align standard and efficient sets of HMs outcomes to measure and evaluate HM data for clinical decisions, long term risk/benefit profile, reimbursement, value analysis, and clinical trials design. Improving outcome measures and endpoint definitions by taking into account “real-life” data and differences in cross-national healthcare practice will undoubtedly result in an optimized, sustainable and effective treatment delivery, as well as in desirable and innovative accelerated pathways for novel drug availability. All these challenges will be addressed within a pan-EU perspective by HARMONY (Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY), a comprehensive public-private European consortium of excellence.
HARMONY consortium is made up of 51 partners: 44 participants from 10 European countries and 7 pharmaceutical companies from the EFPIA. HARMONY aims to assemble, assess, connect, and analyze heterogeneous HM patient derived Big Data sets to define sets of outcome indicators that can be used for decision-making by key healthcare stakeholders. The consortium will orchestrate leading experts and working cooperative groups in HMs, European study alliances, pharmaceutical market leaders, patient advocacy groups, HTA and regulatory agencies, to: (i) optimize Europe-wide data collection and create a high-quality HM data repository for further explorative studies; (ii) establish a clinical data-sharing platform that empowers clinicians, patients and policy stakeholders to improve decision-making procedures and identify appropriate treatments to patients with HMs
“Proof-of-Principle†study | Other | 2020-04-24 02:22:08 |
Case management: Security and Governance FW | Other | 2020-04-24 02:22:08 |
Guidance document on incidental findings | Documents, reports | 2020-04-24 02:22:08 |
Website and repository | Other | 2020-04-24 02:22:08 |
Communication strategy and plan | Documents, reports | 2020-04-24 02:22:08 |
HARMONY platform component deployment | Other | 2020-04-24 02:22:08 |
Definition of all sets of outcomes for individual HMs | Other | 2020-04-24 02:22:08 |
Point of contact/advisors | Documents, reports | 2020-04-24 02:22:08 |
Policy Health Stakeholder Feedback Forum (PHSFF) members identified and established | Documents, reports | 2020-04-24 02:22:08 |
Take a look to the deliverables list in detail: detailed list of HARMONY deliverables.
year | authors and title | journal | last update |
---|---|---|---|
2017 |
Ellen P.B. de Waal Hematology and Big Data published pages: e17, ISSN: 2572-9241, DOI: 10.1097/hs9.0000000000000017 |
HemaSphere 1/1 | 2020-04-24 |
2018 |
Malcikova, J.; Tausch, E.; Rossi, D.; Sutton, L. A.; Soussi, T.; Zenz, T.; Kater, A. P.; Niemann, C. U.; Gonzalez, D.; Davi, F.; Gonzalez Diaz, M.; Moreno, C.; Gaidano, G.; Stamatopoulos, K.; Rosenquist, R.; Stilgenbauer, S.; Ghia, P.; Pospisilova, S. ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia—update on methodological approaches and results interpretation published pages: , ISSN: 0887-6924, DOI: 10.5167/uzh-151201 |
\"Leukemia, Nature Publishing Group: Open Access Hybrid Model Option B, 2018, 32 (5), pp.1070-1080. ⟨10.1038/s41375-017-0007-7⟩\" 1 | 2020-04-24 |
2020 |
Matteo Bersanelli, Ettore Mosca, Luciano Milanesi, Armando Bazzani, Gastone Castellani Frailness and resilience of gene networks predicted by detection of co-occurring mutations via a stochastic perturbative approach published pages: , ISSN: 2045-2322, DOI: 10.1038/s41598-020-59036-w |
Scientific Reports 10/1 | 2020-04-24 |
2019 |
Mattia D\'Agostino, Anders Waage, Juan-José Lahuerta, Uta Bertsch, Elena Zamagni, Lars Bullinger, Alessandra Larocca, Maria-Victoria Mateos, Niels W. C. J. Van De Donk, Hans Jürgen Salwender, Joan Bladé, Bronno van der Holt, Paola Tacchetti, Giovannino Ciccone, Sonja Zweegman, Hartmut Goldschmidt, Michele Cavo, Jesús San-Miguel, Pieter Sonneveld, Mario Boccadoro, Jesús MarÃa Hernández-Rivas Validation and Improvement Opportunities of the Revised International Staging System for Multiple Myeloma: An Analysis on Mature Data from European Clinical Trials within the Harmony Big Data Platform published pages: 1773-1773, ISSN: 0006-4971, DOI: 10.1182/blood-2019-124321 |
Blood 134/Supplement_1 | 2020-04-24 |
2019 |
L. Bullinger, P. Valk, J. Versluis, K. Metzeler, R. Ayala, Martinez J. Lopez, H. Dombret, P. Montesinos, J. Sierra, C. Preudhomme, F. Damm, K. Mills, J. Mayer, C. Thiede, M. T. Voso, S. Amadori, W. Hiddemann, G. Sanz, M. Vukcevic, P. Bacon, Villoria R. Medina, M. Van Speybroeck, R. Goodbody, R. Schulze-Rath, J.-E. Butler-Ransohoff, J. M. Hernández, F. Lo-Coco, B. Huntly, H. Döhner, G. Ossenkoppe HARMONY ALLIANCE: EUROPEAN PUBLIC-PRIVATE DATA COLLECTION LEADS THE WAY - FIRST RESULTS OF THE “PROOF-OF-PRINCIPLE†STUDY IN ACUTE MYELOID LEUKEMIA published pages: 451, ISSN: 2572-9241, DOI: 10.1097/01.hs9.0000562308.58356.23 |
HemaSphere 3 | 2020-04-24 |
2018 |
Ãtalo Faria do Valle, Giulia Menichetti, Giorgia Simonetti, Samantha Bruno, Isabella Zironi, Danielle Fernandes Durso, José C. M. Mombach, Giovanni Martinelli, Gastone Castellani, Daniel Remondini Network integration of multi-tumour omics data suggests novel targeting strategies published pages: 10, ISSN: 2041-1723, DOI: 10.1038/s41467-018-06992-7 |
Nature Communications 9/1 | 2020-04-24 |
2017 |
Miklós Szócska, Sahan Jayawardana, Carin Smand, Tayyab Salimullah, Catherine Reed and Shahid Hanif BIG DATA FOR BETTER OUTCOMES: SUPPORTING HEALTH CARE SYSTEM TRANSFORMATION IN EUROPE published pages: , ISSN: 1356-1030, DOI: |
Eurohealth — Vol.23 | No.1 | 2017 | 2020-04-24 |
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "HARMONY" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "HARMONY" are provided by the European Opendata Portal: CORDIS opendata.
Progress new assets (one pre-new molecular entity and one first-time-in-human start) for tuberculosis that act synergistically with bedaquiline, cytochrome bc or cytochrome bd inhibitors
Read More